Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

Detailed price information for Engene Holdings Inc (ENGN-Q) from The Globe and Mail including charting and trades.

The West Virginia Cancer Institute in Morgantown is now the first healthcare facility in the state to offer a newly regulated cancer therapy, Inlexzo.

Natera submits premarket approval to US FDA for Signatera CDx for detection of MRD in patients with muscle-invasive bladder cancer: Austin, Texas Wednesday, February 4, 2026, 18:0 ...

The key alterations sought are FGFR3 activating mutations or fusions/rearrangements (“susceptible” alterations), for potential use of the FGFR inhibitor erdafitinib (Balversa), and HER2 IHC expression ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

Natera NTRA recently announced the submission of a premarket approval (PMA) application to the FDA for its Signatera CDx test ...

(NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the submission of its premarket approval (PMA) to the U.S. Food and Drug Administration (FDA) for Signatera™ ...

As they navigate complex care, patients turn to tools like AI for greater understanding of their own conditions and treatment ...

Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these ...

The NCCN’s updated guidelines for the treatment of breast cancer include updates on sentinel lymph node biopsy, ovarian ...

Alcohol use disorder may predispose patients to worse adverse in-hospital outcomes after radical cystectomy and ileal conduit urinary diversion for bladder cancer.